Mumbai, Apr 08 : Pharma Major, Zydus Cadila said that it has received the tentative approval from the USFDA to market Lacosamide Tablets in the strengths of 50 mg, 100 mg, 150 mg and 200 mg.
Lacosamide is an anticonvulsant or antiepileptic drug, used to prevent and control seizures. It works by reducing the spread of seizure activity in the brain., company said in a filing with BSE. The drug will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad.
The group now has 261 approvals and has so far filed over 350 ANDAS since the commencement of the filing process in FY 2003-04. (UNI)